You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 2, February 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (79)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Management of Anticoagulation in Outpatients

Experience With an Anticoagulation Service in a Municipal Hospital Setting

Faith B. Davis, MD; Myrna T. Estruch, MD; Esperanza B. Samson-Corvera, MD; Gustav C. Voigt, MD; Jordan D. Tobin, MD

Arch Intern Med. 1977;137(2):197-202.


Abstract

In 66 months, a general hospital's outpatient Anticoagulation Service (ACS) monitored 263 patients who received 280 courses of warfarin sodium totalling 254 patient treatment years. Major hemorrhagic morbidity was 4% of courses and there was no mortality attributable to warfarin therapy. Major hemorrhage occurred in patients with increased anatomic risk of bleeding (diverticulosis, hemorrhoids, cystitis), and was not a function of patient age, sex, anticoagulation control, or medications administered concurrently with warfarin. Control of anticoagulation was not correlated with age or other medications, but was worsened significantly by the presence of congestive heart failure. We attribute a favorable experience with outpatient ACS to careful patient selection, patient education and monitoring, attention to duration of anticoagulation, and continuing communication with primary physicians who retained responsibility for medical care. An ACS offers safety, consistency, efficiency, and a unified approach to outpatient anticoagulation in the general hospital setting.

(Arch Intern Med 137:197-202, 1977)



Author Affiliations

From the Departments of Medicine, Medical School of the State University of New York at Buffalo (Dr Davis), Baltimore City Hospitals, and Johns Hopkins University School of Medicine, Baltimore (Drs Estruch, Samson-Corvera, and Voigt); and the Clinical Physiology Branch, Gerontology Research Center, National Institute on Aging, Baltimore (Dr Tobin).


Footnotes

Accepted for publication June 29, 1976.

Reprint requests to Department of Medicine, Buffalo Veterans Administration Hospital, Buffalo, NY 14215 (Dr Davis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Ansell et al.
Chest 2008;133:160S-198S.
ABSTRACT | FULL TEXT  

The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Ansell et al.
Chest 2004;126:204S-233S.
ABSTRACT | FULL TEXT  

Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Levine et al.
Chest 2004;126:287S-310S.
ABSTRACT | FULL TEXT  

INR Self-Management Permits Lower Anticoagulation Levels After Mechanical Heart Valve Replacement
Koertke et al.
Circulation 2003;108:II-75-78.
ABSTRACT | FULL TEXT  

Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review
Lip and Gibbs
QJM 2002;95:451-459.
ABSTRACT | FULL TEXT  

International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?
Kortke and Korfer
Ann. Thorac. Surg. 2001;72:44-48.
ABSTRACT | FULL TEXT  

How Safely and for How Long Can Warfarin Therapy Be Withheld in Prosthetic Heart Valve Patients Hospitalized With a Major Hemorrhage?
Ananthasubramaniam et al.
Chest 2001;119:478-484.
ABSTRACT | FULL TEXT  

Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119 :22S-38S.
FULL TEXT  

Hemorrhagic Complications of Anticoagulant Treatment
Levine et al.
Chest 2001;119 :108S-121S.
FULL TEXT  

A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin: A Randomized, Controlled Trial
Beyth et al.
ANN INTERN MED 2000;133:687-695.
ABSTRACT | FULL TEXT  

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism
Ansell et al.
ASH Education Book 2000;2000:266-284.
ABSTRACT | FULL TEXT  

Lone Atrial Fibrillation in Elderly Persons: A Marker for Cardiovascular Risk
Kopecky et al.
Arch Intern Med 1999;159:1118-1122.
ABSTRACT | FULL TEXT  

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Chiquette et al.
Arch Intern Med 1998;158:1641-1647.
ABSTRACT | FULL TEXT  

Control of Warfarin Treatment and Problems with the International Normalized Ratio
Bussey and Chiquette
CLIN APPL THROMB HEMOST 1997;3:S16-S23.
 

Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
The Stroke Prevention in Atrial Fibrillation Inves
Arch Intern Med 1996;156:409-416.
ABSTRACT  

Management of Heart Failure: IV. Anticoagulation for Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction
Baker and Wright
JAMA 1994;272:1614-1618.
ABSTRACT  

Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice?
Gottlieb and Salem-Schatz
Arch Intern Med 1994;154:1945-1953.
ABSTRACT  

Guideline-based Consultation To Prevent Anticoagulant-related Bleeding: A Randomized, Controlled Trial in a Teaching Hospital
Landefeld and Anderson
ANN INTERN MED 1992;116:829-837.
ABSTRACT  

Physicians' Attitudes Toward Oral Anticoagulants and Antiplatelet Agents for Stroke Prevention in Elderly Patients With Atrial Fibrillation
Kutner et al.
Arch Intern Med 1991;151:1950-1953.
ABSTRACT  

Cost-Benefit Issues in the Practice of Internal Medicine
Friedman and Katt
Arch Intern Med 1991;151:1165-1168.
ABSTRACT  

Home Prothrombin Time Monitoring after the Initiation of Warfarin Therapy: A Randomized, Prospective Study
White et al.
ANN INTERN MED 1989;111:730-737.
ABSTRACT  

Acute Abdominal Conditions Induced by Anticoagulant Therapy Case Reports
Stanton et al.
VASC ENDOVASCULAR SURG 1988;22:413-421.
ABSTRACT  

Age-Related Risks of Long-term Oral Anticoagulant Therapy
Gurwitz et al.
Arch Intern Med 1988;148:1733-1736.
ABSTRACT  

Spontaneous Retroperitoneal Hemorrhage During Oral Anticoagulant Therapy
Palleja et al.
Arch Intern Med 1985;145:1531-1534.
ABSTRACT  

Management of Oral Anticoagulant Therapy: Experience With an Anticoagulation Clinic
Errichetti et al.
Arch Intern Med 1984;144:1966-1968.
ABSTRACT  

Influenza Vaccination and Warfarin Anticoagulation
LIPSKY et al.
ANN INTERN MED 1984;100:835-837.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.